LSERS
SCLN

Louisiana State Employees Retirement System’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Louisiana State Employees Retirement System’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-21,200
Closed -$237K – 1478
2017
Q3 		$237K Buy
21,200
+100
+0.5% +$1.1K 0.01% 1372
2017
Q2 		$232K Buy
21,100
+100
+0.5% +$1K 0.01% 1368
2017
Q1 		$206K Buy
21,000
+500
+2% +$4.99K 0.01% 1393
2016
Q4 		$221K Sell
20,500
-1,600
-7% -$16K 0.01% 1375
2016
Q3 		$227K Hold
22,100
– – 0.01% 1361
2016
Q2 		$289K Buy
+22,100
New +$290K 0.02% 1277

Louisiana State Employees Retirement System's SCLN Position: Q4 2017 in Review

Louisiana State Employees Retirement System sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 21,200 shares — an estimated $237K sold.

Louisiana State Employees Retirement System first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $289K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Louisiana State Employees Retirement System reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 21,200 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $237K.
  • Louisiana State Employees Retirement System first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • Louisiana State Employees Retirement System's Sciclone Pharmaceuticals Inc position peaked at $289K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Louisiana State Employees Retirement System's 13F filing for Q4 2017, filed 16 Jan 2018.